Request for Information No. 7200AA25RFI00003: NextGen Medical Product Quality Assurance and Production Systems (MedQAPS)
This initiative seeks input from organizations and experts to help USAID improve global medical product quality assurance and production systems, focusing on innovative solutions and partnerships.
Description
The document titled "Request for Information (RFI) No. 7200AA25RFI00003: NextGen Medical Product Quality Assurance and Production Systems" outlines USAID's intent to gather information for planning and designing a future activity focused on strengthening medical product quality assurance and production systems.
The RFI is intended solely for information-gathering and planning purposes. It does not constitute a funding opportunity, grant, or contract. USAID clarifies that the RFI does not guarantee the release of a solicitation or an award. Interested parties are invited to provide feedback to help shape USAID's approach to enhancing medical product quality and production systems globally.
USAID seeks input on the draft program description provided in Attachment 1 and requests respondents to follow the submission guidelines outlined in Attachment 2. Responses should be prepared using the specified Response Template/Structure. The agency aims to identify critical insights and innovative approaches that will inform the final design of the anticipated activity.
Respondents are encouraged to address specific questions posed in the RFI, focusing on areas such as technical priorities, key challenges, opportunities for partnerships, and recommendations for achieving program objectives. USAID also welcomes suggestions on operational models and approaches to maximize sustainability and local ownership.
Submissions must adhere to the deadlines and instructions provided in the document. Respondents are reminded that participation in this RFI is voluntary, and no compensation or reimbursement will be provided for time or expenses incurred in preparing responses.
USAID emphasizes the importance of clear, concise, and actionable feedback to ensure that the final program design aligns with global health priorities and effectively addresses identified gaps in medical product quality assurance and production systems.